INTRODUCTION
============

Centronuclear myopathy (CNM) is a rare congenital myopathy, which was first described as myotubular myopathy by Spiro et al.[@B001] in 1966. The muscle biopsy is characterized by myofibers with centrally placed nucleoli, which are reminiscent of the myotube stage of muscle development. The authors suggested that it originated from an arrested maturation of embryonic muscle. Hence, the condition was called myotubular myopathy. It remains unclear if muscle development was arrested; therefore the term "centronuclear myopathies" was preferred, especially for the late onset forms. The term "myotubular" is now used to denote severe infantile cases, and reserve CNM denotes clinically milder cases affecting older patients in whom the muscle biopsy tends to appear "more mature."[@B002]^-^[@B004]

CNM is usually caused by a mutation in the myotubularin (*MTM1*), amphiphysin 2 (*BIN1*), and dynamin 2 (*DNM2*) genes, which are involved in membrane remodeling and trafficking, suggesting a common CNM pathophysiology.[@B005] In addition to CNM, dissimilar *DNM2* mutations are associated with Charcot--Marie--Tooth (CMT) peripheral neuropathy (CMTD1B and CMT2M), indicating a tissue-specific impact of the mutations. Defects in membrane trafficking due to *DNM2* mutations potentially represent a common pathological mechanism in CNM and CMT.[@B006]

Three main forms of CNM are recognized according to the mode of inheritance and clinical presentation[@B007] ([Table 1](#t01){ref-type="table"}):

###### Centronuclear myopathies

  Centronuclear myopathy                                                           Mutation                                                  Clinical presentation                                                                                              Microscopic features
  -------------------------------------------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  XLMTM                                                                            *MTM1* gene (Xq28)                                        Usually males, hypotonia, respiratory failure at birth, facial weakness, ptosis, and extraocular muscle weakness   Fibers with central nuclei resembling myotubes, which are frequently surrounded by a paler peripheral halo
  Heterozygous female carriers may present with limb girdle and facial weakness    Some muscle fibers that resemble a "necklace"                                                                                                                                
  ARCNM                                                                            *BIN1* gene (2q14.3)                                      Early onset with ophthalmoparesis: tend to be more severely affected and may present with dysmorphic features      Large majority of rounded fibers with centralized nuclei and an increase of endomysial fibrosis; some fibers have clusters of centrally placed nuclei
  *RYR1* gene (19q13.2)                                                            Early onset without ophthalmoparesis                                                                                                                                         
  *TTN* gene (2q31.2)                                                              Late onset without ophthalmoparesis: (similar to ADCNM)                                                                                                                      
  ADCNM                                                                            *DNM2* gene (19p13.2)                                     Classic form: it is characterized by late onset (may present in the patient's 30s) and slow progression            Numerous fibers with centrally located nuclei and sarcoplasmic strands radiating from the central nucleus ("spoke-like appearance"), hypotrophy of type 1 fibers
  With muscle hypertrophy: it presents at a younger age with a more rapid course                                                                                                                                                                                

ADCNM = autosomal dominant centronuclear myopathy; ARCNM = autosomal recessive centronuclear myopathy; XLMTM = X-linked myotubular myopathy.

1.  **X-linked myotubular myopathy (XLMTM):** This form of CNM is the most severe and the most commonly diagnosed type, which is caused by a mutation in the *MTM1* gene located at Xq27-q28.[@B004]^,^[@B008] Almost all cases occur in males and present with severe hypotonia, which frequently causes respiratory failure at birth. Facial weakness, ptosis, and extraocular muscle weakness are common. Rarely, abnormal genital development occurs.[@B009] Heterozygous female carriers may present with limb girdle and facial weakness.[@B010] Mutations in *MTM1* have also been recognized as the underlying cause of atypical forms of XLMTM in newborn boys, female infants, and adult men and women, which presents a histological alteration in some muscle fibers that resemble a necklace ("necklace fibers").[@B011] Muscle biopsies from XLMTM patients show numerous fibers with central nuclei resembling myotubes, which are frequently surrounded by a paler peripheral halo. These perinuclear paler halos are due to mitochondria aggregates, glycogen granules, and a reduction in myofilaments.[@B012]^,^[@B013]

2.  **Autosomal recessive CNM (ARCNM):** This form presents with relatively mild weakness that may be unrecognized in the neonatal period. It is caused by mutations in the bridging integrator 1 gene (*BIN1*).[@B014]^,^[@B015] Mutations in the *RYR1* gene have also been described in patients with congenital myopathy with central nuclei, although it is now recognized that these patients have a form of *RYR1*-related congenital myopathy rather than CNM.[@B016]^,^[@B017] Recessive mutations in *TTN* that encode the giant sarcomeric ruler protein, titin, have also been identified in some patients with congenital myopathies with central nuclei.[@B018] The muscle biopsies in *BIN1*-related CNM show a large majority of rounded fibers with centralized nuclei and an increased amount of endomysial fibrosis; some fibers have clusters of centrally placed nuclei on H&E staining. The presence or absence of ophthalmoparesis in early onset cases has been suggested as a means to clinically classify ARCNM into three subgroups:[@B019] (i) early onset with ophthalmoparesis: patients tend to be more severely affected and may present with dysmorphic features; (ii) early onset without ophthalmoparesis; and (iii) late onset without ophthalmoparesis: affected patients have a clinical phenotype similar to patients with autosomal dominant CNM.

3.  **Autosomal dominant CNM (ADCNM):** This disorder not only involves mainly limb girdle, trunk, and neck muscles, but also it may affect the distal muscles. Weakness may not become evident until the third decade of life. It is caused by a mutation in dynamin 2 (*DNM2*) on chromosome 19.[@B020] The most prominent histopathological features include the frequency of centrally located nuclei in a large number of the extrafusal muscle fibers, the radial arrangement of sarcoplasmic strands around the central nuclei, and the predominance and hypotrophy of type 1 fibers. ADCNM can be divided to two subgroups due to the presence or absence of muscle hypertrophy:[@B019] (i) classic form: this is characterized by late onset and slow progression; and (ii) with muscle hypertrophy: this usually presents at a younger age and has a more rapid course.

CASE REPORT
===========

A 17-year-old Caucasian female with a past medical history of anomalous pulmonary venous connection (left to right shunt), biphasic thoracolumbar scoliosis, and restrictive lung disease, presented with progressive proximal muscle weakness and lumbar pain. There was no specific family history of neurological disease. Upon physical examination, we observed levoscoliosis and weakness in the bilateral upper extremities (4/5) and the lower extremities (3/5). She was unable to walk on her toes or heels, and was unable to arise from a squatting position, although her gait was not grossly abnormal on observation. There was no facial weakness, and her extraocular movements were intact. Sensory examination showed intact sensation bilaterally. There was no spasticity, Babinski sign, or ankle clonus.

An x-ray showed scoliosis and kyphoscoliosis. Magnetic resonance imaging findings were suggestive of paraspinal muscle edema suspicious for an underlying myopathy process. A partial anomalous pulmonary venous return with left to right shunt was also observed. An electromyography (EMG) showed electrodiagnostic evidence of diffuse myopathic process. The creatine kinase (CK) level was normal: 68 (reference range: 0-250 U/L).

The microscopic examination of the muscle biopsy (left vastus lateralis) showed excess variability in fiber size ([Figure 1A](#g01){ref-type="fig"}), and frequent myonuclei in the center of the muscle fibers ([Figure 1B](#g01){ref-type="fig"}), which often formed chains when viewed longitudinally ([Figure 1C](#g01){ref-type="fig"}). Degenerating fibers, angulated, split fibers, and nuclear bags were not present. Myophagocytosis was not present, and inflammatory infiltrates were not seen. Rare fibers contained central red stippling; however, definitive ragged red fibers were not seen. NADH histochemistry showed increased reaction in the center of some fibers with radial arrangement of the intermyofibrillar network radiating from the central nucleus (a spoke-like appearance on the fibers) ([Figure 1D](#g01){ref-type="fig"}).

![Photomicrography of the muscle biopsy. **A** - Fiber size variation and centralized nuclei especially in small fibers (H&E); **B** - Central nuclei are observed in majority of cells (H&E); **C** - Centrally located nuclei often forming chains in a longitudinal section (H&E); **D** - Radial arrangement of inter-myofibrillar network (spoke-like appearance) (NADH stain).](autopsy-07-02043-g01){#g01}

ATPase (pH 9.8, 4.6, 4.3) histochemical stains show type I fiber predominating (more than 90%), and type II fibers were normal in size or were hypertrophic ([Figure 2A](#g02){ref-type="fig"}). Electron microscopy with toluidine blue staining showed disruption of myofibers particularly around the central nuclei ([Figure 2B](#g02){ref-type="fig"}). Glycogen content appeared mildly increased in areas, and scattered collections of mitochondria and occasional nonspecific inclusions were noted.

![Photomicrography of the muscle biopsy. **A** - ATPase (pH 4.3) type II fiber hypertrophy and type I fiber predominance (\>90%); **B** - Electronic microscopy: fibers with central nuclei and radial sarcoplasmic strands (X 6300).](autopsy-07-02043-g02){#g02}

Mitochondrial DNA (mtDNA) whole genome sequencing was performed at a third-party lab (using the internal guidelines at the Medical Neurogenetic Lab, State of Georgia license \#044-146) and showed a heterozygous missense variant in exon 11 of the *DNM2* gene located on chromosome 19; DNM2 (NM_001005360.2):c.1393C\>T: p.Arg465Trp. This variant corresponded to the SNP rs121909091 and had been observed previously in at least three individuals with CNM, according to the ClinVar database. It is not found in more than 60,000 controls in the ExAC database.[@B021]

DISCUSSION
==========

CNM is a rare congenital myopathy, which can be diagnosed based on histology. Three forms of the disease are clinically recognized: (i) the X-linked severe neonatal form, which is caused by *MTM1* mutation; (ii) the autosomal recessive childhood onset form, which is usually caused by *BIN1* mutation; and (iii) the autosomal dominant adult-onset form, which is caused by *DNM2* mutation. Genotype--phenotype correlation hypotheses are drawn from published and new data and allow an efficient screening strategy for molecular diagnosis. Here, we report the clinical, pathological, and molecular characteristics of a 17-year-old patient with *DNM2*-related CNM, which was confirmed by genetic testing. The patient presented with muscle weakness and associated disabilities (thoracolumbar scoliosis with restrictive lung disease), as well as anomalous pulmonary venous connection. Because the cardiac abnormality has not been described in patients with *DNM2*-related CNM, it is not clear whether it could be just a co-occurrence condition or the first description of this new finding. Therefore, more evidence is needed to conclude this matter. The laboratory work-up showed normal blood CK levels; however, the EMG study was consistent with myopathy. The microscopic and histochemistry studies of the muscle biopsy showed radial oxidative staining of sarcoplasmic strands (on NADH staining) and type I muscle fiber predominance with type II muscle fiber hypertrophy (on ATPase staining), which was suggestive of *DNM2*-related changes. A further genetic work-up revealed a *DNM2* mutation on chromosome 19, and confirmed the diagnosis of ADCNM.
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